Tuberculosis is a contagious disease caused by Mycobacterium tuberculosis that mainly affects the lungs. Although effective treatments are available, they are associated with long treatment durations, drug toxicity, and drug resistance.
To combat this, the updated changes focus on shorter, safer, and more effective treatment strategies.
The key changes include:
-
A four-month regimen instead of a six-month regimen for adults and adolescents aged 12 years or older with drug-susceptible pulmonary TB.
-
Children with non-severe TB disease can be treated in four months instead of six months.
-
For multidrug-resistant TB, the treatment duration has been reduced from fifteen months to six months.
-
For rifampin-resistant TB, the treatment duration has been reduced from fifteen months to six months.
However, these guidelines are meant for low-incidence settings where advanced diagnostic tools are routinely available.
How these new guidelines reshape the standard of care:
-
Shorter duration improves treatment completion rates.
-
Fewer side effects.
-
Less burden on patients.
-
Better patient care.
Modern TB management embraces all-oral, shorter treatment regimens, reducing the burden on patients and making treatment safer, faster, and more effective.
Have you come across these updated TB guidelines?
For more info visit on